UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $140,899 | +1.9% | 10,057 | -24.7% | 0.00% | – |
Q2 2023 | $138,224 | -82.4% | 13,355 | -84.3% | 0.00% | – |
Q1 2023 | $784,199 | -43.3% | 84,870 | +18.3% | 0.00% | – |
Q3 2020 | $1,383,000 | -26.9% | 71,738 | -0.9% | 0.00% | – |
Q2 2020 | $1,891,000 | +632.9% | 72,366 | +400.1% | 0.00% | – |
Q1 2020 | $258,000 | -75.6% | 14,469 | -54.4% | 0.00% | -100.0% |
Q4 2019 | $1,058,000 | +366.1% | 31,719 | +595.1% | 0.00% | 0.0% |
Q2 2018 | $227,000 | – | 4,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |